RA Capital Management, L.P. 13D/13G Filings for Bolt Biotherapeutics, Inc. (BOLT)

RA Capital Management, L.P. 13D and 13G filings for Bolt Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-05-16
4:31 pm
Sale
2022-05-1613GBolt Biotherapeutics, Inc.
BOLT
RA Capital Management, L.P.0
0.000%
-2,378,325decrease
(Position Closed)
Filing
2021-04-07
4:30 pm
Purchase
2021-04-0113GBolt Biotherapeutics, Inc.
BOLT
RA Capital Management, L.P.2,378,325
6.500%
2,378,325increase
(New Position)
Filing